3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
17
Colorectal Neoplasms
14
Neoplasms
13
Carcinoma, Hepatocellular
11
Prostatic Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Stomach Neoplasms
5
Anastomotic Leak
5
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Ovarian Neoplasms
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Stomatitis
3
Recurrence
3
Pancreatic Neoplasms
3
Myeloproliferative Disorders
3
Lymphoma
3
HIV Infections
3
Disease
3
Depression
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Vulvar Neoplasms
2
Surgical Wound Infection
2
Sleep Initiation and Maintenance Disorders
2
Skin Neoplasms
2
Sarcoma
2
Postoperative Complications
2
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Hepatic Insufficiency
×
90 days
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled